We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+4.01%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$6.7B
AUM Growth
+$144M
Cap. Flow
+$80.4M
Cap. Flow %
1.2%
Top 10 Hldgs %
21%
Holding
1,675
New
169
Increased
710
Reduced
579
Closed
127

Sector Composition

Rank Sector Weight
1 Technology 21.11%
2 Financials 10.66%
3 Industrials 8.29%
4 Consumer Discretionary 7.5%
5 Healthcare 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVTR icon
1401
Eaton Vance Total Return Bond ETF
EVTR
$5.64B
$229K ﹤0.01%
4,598
-1,000
-18% -$50.6K
NIO icon
1402
NIO
NIO
$11.9B
$228K ﹤0.01%
52,332
-25,729
-33% -$131K
ENLC
1403
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$228K ﹤0.01%
16,100
TARS icon
1404
Tarsus Pharmaceuticals
TARS
$2.55B
$227K ﹤0.01%
+4,100
New +$186K
TEVA icon
1405
Teva Pharmaceuticals
TEVA
$40.4B
$227K ﹤0.01%
10,278
-22,124
-68% -$402K
GPGI
1406
GPGI Inc
GPGI
$3.87B
$226K ﹤0.01%
+17,746
New +$225K
GTLS.PRB
1407
DELISTED
Chart Industries 6.75% Series B Preferred Stock
GTLS.PRB
$226K ﹤0.01%
3,200
-1,000
-24% -$61.8K
CELH icon
1408
Celsius Holdings
CELH
$7.38B
$225K ﹤0.01%
8,561
-3,350
-28% -$99.4K
ETY icon
1409
Eaton Vance Tax-Managed Diversified Equity Income Fund
ETY
$2.24B
$225K ﹤0.01%
+15,082
New +$224K
NWN icon
1410
Northwest Natural Holdings
NWN
$2.15B
$225K ﹤0.01%
5,675
TAC icon
1411
TransAlta
TAC
$3.93B
$223K ﹤0.01%
15,793
-2,967
-16% -$33.9K
AMTM
1412
Amentum Holdings
AMTM
$5.33B
$223K ﹤0.01%
10,621
-35,012
-77% -$905K
MUR icon
1413
Murphy Oil
MUR
$5.55B
$223K ﹤0.01%
7,376
-592
-7% -$19K
CGSD icon
1414
Capital Group Short Duration Income ETF
CGSD
$2.39B
$223K ﹤0.01%
8,700
HEFA icon
1415
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.45B
$221K ﹤0.01%
6,373
+230
+4% +$8.1K
MFIC icon
1416
MidCap Financial Investment
MFIC
$801M
$221K ﹤0.01%
+16,387
New +$223K
CLVT icon
1417
Clarivate
CLVT
$1.38B
$221K ﹤0.01%
+43,500
New +$251K
BME icon
1418
BlackRock Health Sciences Trust
BME
$569M
$220K ﹤0.01%
5,809
-83
-1% -$3.31K
SUSA icon
1419
iShares ESG Optimized MSCI USA ETF
SUSA
$3.95B
$219K ﹤0.01%
1,804
+4
+0.2% +$491
SWK icon
1420
Stanley Black & Decker
SWK
$14.5B
$219K ﹤0.01%
2,729
-1,095
-29% -$102K
TBIL
1421
F/m US Treasury 3 Month Bill Fund
TBIL
$7.19B
$219K ﹤0.01%
+4,383
New +$219K
HLN icon
1422
Haleon
HLN
$45.3B
$217K ﹤0.01%
22,798
+248
+1% +$2.43K
DTE icon
1423
DTE Energy
DTE
$29.9B
$217K ﹤0.01%
+1,800
New +$222K
PZA icon
1424
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.23B
$217K ﹤0.01%
+9,196
New +$220K
LEG icon
1425
Leggett & Platt
LEG
$1.4B
$216K ﹤0.01%
22,501
-120
-0.5% -$1.44K

Similar funds

Oppenheimer & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Oppenheimer & Co held 1,675 positions worth $6.7B, up 2.2% from $6.56B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Oppenheimer & Co's Q4 2024 filing shows 169 new, 710 increased, 579 reduced and 127 closed positions. Its largest new stake was FT Vest US Equity Deep Buffer ETF November: 493,441 shares worth $21.2M. The largest sale was FT Vest US Equity Deep Buffer ETF March, an estimated $21.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.

  • Oppenheimer & Co's largest Q4 2024 buy was FT Vest US Equity Deep Buffer ETF November: 493,441 shares worth $21.2M.
  • Oppenheimer & Co added most to iShares Russell Mid-Cap Growth ETF in Q4 2024, an estimated $12.8M increase.
  • Oppenheimer & Co's biggest Q4 2024 reduction was FT Vest US Equity Deep Buffer ETF March, cutting an estimated $21.8M.
  • Oppenheimer & Co fully exited Innovative Industrial Properties in Q4 2024, selling an estimated $6.32M.
  • Oppenheimer & Co's ten largest holdings make up 21% of its $6.7B portfolio in Q4 2024.
  • Oppenheimer & Co opened 169 new positions and closed 127 in Q4 2024.
  • Oppenheimer & Co's portfolio value rose 2.2% quarter-over-quarter to $6.7B.

Based on Oppenheimer & Co's 13F filing for Q4 2024, filed 5 Feb 2025.